Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
59.61
+0.59 (1.00%)
At close: Oct 8, 2025, 4:00 PM EDT
59.78
+0.17 (0.29%)
After-hours: Oct 8, 2025, 5:51 PM EDT
Novo Nordisk Stock Forecast
Stock Price Forecast
The 5 analysts that cover Novo Nordisk stock have a consensus rating of "Buy" and an average price target of $82.2, which forecasts a 37.90% increase in the stock price over the next year. The lowest target is $47 and the highest is $160.
Price Target: $82.2 (+37.90%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Novo Nordisk stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 | 3 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 3 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 6 | 7 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HSBC | HSBC | Hold → Strong Buy Upgrades $70 | Hold → Strong Buy | Upgrades | $70 | +17.43% | Oct 2, 2025 |
| Morgan Stanley | Morgan Stanley | Hold → Sell Downgrades $59 → $47 | Hold → Sell | Downgrades | $59 → $47 | -21.15% | Sep 29, 2025 |
| Berenberg | Berenberg | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Sep 17, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $105 → $70 | Strong Buy | Maintains | $105 → $70 | +17.43% | Aug 19, 2025 |
| UBS | UBS | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 5, 2025 |
Financial Forecast
Revenue This Year
318.23B
from 290.40B
Increased by 9.58%
Revenue Next Year
341.74B
from 318.23B
Increased by 7.39%
EPS This Year
24.71
from 22.63
Increased by 9.19%
EPS Next Year
26.86
from 24.71
Increased by 8.69%
Financial currency is DKK. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 338.1B | 401.5B | |||
| Avg | 318.2B | 341.7B | |||
| Low | 301.0B | 308.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 16.4% | 26.2% | |||
| Avg | 9.6% | 7.4% | |||
| Low | 3.7% | -3.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 27.65 | 33.34 | |||
| Avg | 24.71 | 26.86 | |||
| Low | 21.83 | 23.66 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 22.2% | 34.9% | |||
| Avg | 9.2% | 8.7% | |||
| Low | -3.5% | -4.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.